BSEMediumNeutral
Announced Wed, 14 May · 19:52 IST

Re-appointment of Non-Executive Independent Director

Management Changes View source PDF
Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

J. B. Chemicals & Pharmaceuticals has re-appointed Mr. Sumit Bose (DIN: 03340616) as an Independent Director for a second term of 5 years, effective August 31, 2025, subject to shareholder approval. Mr. Bose is a retired IAS officer who previously served as Union Finance Secretary and held other senior positions in the Government of India. He currently serves on boards of several companies including HDFC Life Insurance, JM Financial, and BSE Limited. He is not debarred from holding directorship and has no inter-director relationships.

Likely market impact

This is a routine governance update with no material impact on shareholders. The re-appointment of a highly experienced independent director signals continuity on the board and reinforces governance standards.